Which signals induce this cellular state in tumours remains unclear, but CXCL9 expression by cDC1s can be augmented therapeutically by increasing uptake of tumour‐derived DNA in response to TIM‐3 blockade [30]. This evidence concerns the gene HAVCR2 and neoplasm.